BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Rowe PS, Zelenchuk LV, Laurence JS, Lee P, Brooks WM, McCarthy ET. Do ASARM peptides play a role in nephrogenic systemic fibrosis? Am J Physiol Renal Physiol 2015;309:F764-9. [PMID: 26336161 DOI: 10.1152/ajprenal.00201.2015] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
Number Citing Articles
1 Lancelot E. Revisiting the Pharmacokinetic Profiles of Gadolinium-Based Contrast Agents: Differences in Long-Term Biodistribution and Excretion. Invest Radiol 2016;51:691-700. [DOI: 10.1097/rli.0000000000000280] [Cited by in Crossref: 62] [Cited by in F6Publishing: 18] [Article Influence: 10.3] [Reference Citation Analysis]
2 Knoepp F, Bettmer J, Fronius M. Gadolinium released by the linear gadolinium-based contrast-agent Gd-DTPA decreases the activity of human epithelial Na+ channels (ENaCs). Biochim Biophys Acta Biomembr 2017;1859:1040-8. [PMID: 28257815 DOI: 10.1016/j.bbamem.2017.02.019] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
3 Garcia J, Liu SZ, Louie AY. Biological effects of MRI contrast agents: gadolinium retention, potential mechanisms and a role for phosphorus. Philos Trans A Math Phys Eng Sci 2017;375:20170180. [PMID: 29038383 DOI: 10.1098/rsta.2017.0180] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 5.7] [Reference Citation Analysis]
4 Rasschaert M, Idée JM, Robert P, Fretellier N, Vives V, Violas X, Ballet S, Corot C. Moderate Renal Failure Accentuates T1 Signal Enhancement in the Deep Cerebellar Nuclei of Gadodiamide-Treated Rats. Invest Radiol 2017;52:255-64. [PMID: 28067754 DOI: 10.1097/RLI.0000000000000339] [Cited by in Crossref: 35] [Cited by in F6Publishing: 16] [Article Influence: 7.0] [Reference Citation Analysis]
5 Kartamihardja AA, Nakajima T, Kameo S, Koyama H, Tsushima Y. Impact of Impaired Renal Function on Gadolinium Retention After Administration of Gadolinium-Based Contrast Agents in a Mouse Model. Invest Radiol 2016;51:655-60. [PMID: 27299580 DOI: 10.1097/RLI.0000000000000295] [Cited by in Crossref: 39] [Cited by in F6Publishing: 21] [Article Influence: 7.8] [Reference Citation Analysis]